Benitec Biopharma (BNTC)
(Delayed Data from NSDQ)
$8.93 USD
+0.27 (3.12%)
Updated Aug 9, 2024 03:40 PM ET
After-Market: $8.90 -0.03 (-0.34%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum F VGM
Brokerage Reports
Benitec Biopharma Limited [BNTC]
Reports for Purchase
Showing records 1 - 6 ( 6 total )
Company: Benitec Biopharma Limited
Industry: Medical - Biomedical and Genetics
Company: Benitec Biopharma Limited
Industry: Medical - Biomedical and Genetics
F1Q23 Results; Lead Program BB-301 Nearing IND Submission and the Start of the Phase 1b/2a Trial in OPMD
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Benitec Biopharma Limited
Industry: Medical - Biomedical and Genetics
F4Q22 Results; Lead Program BB-301 to Advance to Phase 1b/2a Study in 2023; Lowering Price Target to $4; Maintain Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Benitec Biopharma Limited
Industry: Medical - Biomedical and Genetics
F3Q22 Results; Lead Program BB-301 Progressing on Track; Compelling Valuation Ahead of Expected Program Updates
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Benitec Biopharma Limited
Industry: Medical - Biomedical and Genetics
Company: Benitec Biopharma Limited
Industry: Medical - Biomedical and Genetics
|